Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Phase III study of gemcitabine/oxaliplatin (GEMOX) with or without erlotinib in unresectable, metastatic biliary tract carcinoma.
- Authors
- Lim, H. Y.; Lee, J.; Chang, H.; Kim, J. S.; Choi, H. J.; Lee, M. A.; Jang, J.; Jeung, H.; Kang, J. H.; Lee, H. W.; Shin, D.; Jang, H. J.; Sun, J.; Park, S. H.; Park, J. O.; Park, Y.; Kang, W. K.
- Issue Date
- 20110520
- Conference Name
- JOURNAL OF CLINICAL ONCOLOGY
- Place
- 미국
Chicago, IL
- Conference Name
- 2011 ASCO Annual Meeting
- ISSN
- 0732-183X
1527-7755
- Files in This Item
- There are no files associated with this item.
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Kim, Jun Suk
- Guro Hospital (Department of Medical Oncology and Hematology, Guro Hospital)